Vicentic A, Lakatos A, Kuhar MJ., 2005, Eur J Pharmacol. 528(1-3):188-9.
Neuroscience Division, Yerkes National Primate Research Center of Emory University, 954 North Gatewood Road, Atlanta Georgia 30033, USA. firstname.lastname@example.org
Given previous evidence for CART (cocaine- and amphetamine-regulated transcript) signaling in AtT20 cells, the binding of [125I]-CART61-102 was characterized in these cells. The binding was specific, saturable, dependent on time, pH, temperature and protein concentration, with a Bmax of 101.4+/-8.8 fmol/mg protein and a Kd of 21.9+/-8.0 pM. Only active CART55-102, but not other peptides or drugs, inhibited the [125I]-CART61-102 binding. These data are the first demonstration of specific receptor binding for CART peptides.
*Custom peptides and IgY antibodies used in this publication were produced by Gallus Immunotech Inc. Please visit ourCustom Peptide Synthesis and Custom IgY production page for more information.